CAIROLI, ROBERTO
CAIROLI, ROBERTO
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
A GIMEMA survey on therapeutic use and response rates of FLT3 inhibitors in acute myeloid leukemia: Insights from Italian real‐world practice
2024 Messina, M; Piciocchi, A; Siena, L; Soddu, S; Buccisano, F; Mecucci, C; Martinelli, G; Curti, A; Cairoli, R; Fazi, P; Vignetti, M; Voso, M; Venditti, A; Candoni, A
Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination.—Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica Lombarda
2024 Rossi, G; Borlenghi, E; Zappasodi, P; Lussana, F; Bernardi, M; Basilico, C; Molteni, A; Lotesoriere, I; Turrini, M; Frigeni, M; Fumagalli, M; Cozzi, P; Gigli, F; Cattaneo, C; Fracchiolla, N; Riva, M; Martini, G; Mancini, V; Cairoli, R; Todisco, E
Advances in the understanding of molecular genetics and therapy ofRichter transformation in chronic lymphocytic leukemia
2024 Deodato, M; Frustaci, A; Zappaterra, A; Rapella, A; Gambacorti-Passerini, C; Cairoli, R; Montillo, M; Tedeschi, A
Anti-CD38 monoclonal antibody impairs CD34+ mobilization and affects clonogenic potential in multiple myeloma patients
2024 Zappaterra, A; Civettini, I; Cafro, A; Pezzetti, L; Pierini, S; Anghilieri, M; Bellio, L; Bertazzoni, P; Grillo, G; Minga, P; Pioltelli, M; Ravano, E; Sassone, M; Viganò, C; Volpato, E; Gambacorti-Passerini, C; Rossini, S; Cairoli, R; Crocchiolo, R
Atezolizumab, venetoclax, and obinutuzumab combination in Richter transformation diffuse large B-cell lymphoma (MOLTO): a multicentre, single-arm, phase 2 trial
2024 Tedeschi, A; Frustaci, A; Condoluci, A; Coscia, M; Chiarle, R; Zinzani, P; Motta, M; Gaidano, G; Quaresmini, G; Scarfò, L; Catania, G; Deodato, M; Jones, R; Tabanelli, V; Griggio, V; Stüssi, G; Calleri, A; Pini, K; Cairoli, R; Zenz, T; Signori, A; Zucca, E; Rossi, D; Montillo, M
Cerebral Infectious Opportunistic Lesions in a Patient with Acute Myeloid Leukaemia: The Challenge of Diagnosis and Clinical Management
2024 Cavazza, G; Motto, C; Regna-Gladin, C; Travi, G; Di Gennaro, E; Peracchi, F; Monti, B; Corti, N; Greco, R; Minga, P; Riva, M; Rimoldi, S; Vecchi, M; Rogati, C; Motta, D; Pazzi, A; Vismara, C; Bandiera, L; Crippa, F; Mancini, V; Sessa, M; Oltolini, C; Cairoli, R; Puoti, M
Communicating the diagnosis of a hematological neoplastic disease to patients’ minor children: a multicenter prospective study
2024 Manghisi, B; Borin, L; Monaco, M; Sacco, G; Antolini, L; Mantegazza, R; Barichello, M; Mazza, U; Zappasodi, P; Onida, F; Arcaini, L; Cairoli, R; Gambacorti Passerini, C
Efficacy of Midostaurin Combined With Intensive Chemotherapy in Core Binding Factor Leukemia: A Phase II Clinical Trial
2024 Cairoli, R; Gatti, A; Grillo, G; Stefanucci, M; Di Camillo, B; Fumagalli, M; Krampera, M; Nadali, G; Zappasodi, P; Borlenghi, E; Todisco, E; Ubezio, M; Bernardi, M; Molteni, A; Basilico, C; Turrini, M; Greco, R; Mancini, V; Riva, M; Bernasconi, D; Brando, B; Veronese, S; Beghini, A
Exploring the administrative burden faced by hematologists: a comprehensive study in Italy
2024 Petruzzelli, D; Vignetti, M; Trasarti, S; Sportoletti, P; Della Torre, S; Cairoli, R; Leone, F; Pompilio, G; Gullì, M; Brown Hajdukova, E; Integlia, D
Fasting and Diet: Overview in Chronic Lymphocytic Leukemia
2024 Trojani, A; Bossi, L; Cairoli, R
Gilteritinib as Post-Transplant Maintenance for Acute Myeloid Leukemia With Internal Tandem Duplication Mutation of FLT3
2024 Levis, M; Hamadani, M; Logan, B; Jones, R; Singh, A; Litzow, M; Wingard, J; Papadopoulos, E; Perl, A; Soiffer, R; Ustun, C; Ueda Oshima, M; Uy, G; Waller, E; Vasu, S; Solh, M; Mishra, A; Muffly, L; Kim, H; Mikesch, J; Najima, Y; Onozawa, M; Thomson, K; Nagler, A; Wei, A; Marcucci, G; Geller, N; Hasabou, N; Delgado, D; Rosales, M; Hill, J; Gill, S; Nuthethi, R; King, D; Wittsack, H; Mendizabal, A; Devine, S; Horowitz, M; Chen, Y; Agura, E; Altman, J; Anagnostopoulos, A; Anand, S; Artz, A; Aulitzky, W; Balderman, S; Ballen, K; Becker, M; Beguin, Y; Berkahn, L; Berneman, Z; Bhatt, V; Bilmon, I; Bonifazi, F; Briggs, A; Bruno, B; Brunstein, C; Byrne, M; Byrne, J; Cabrero, M; Cairoli, R; Carrum, G; Cerny, J; Chen, Y; Cheong, J; Ciceri, F; Colorado, M; Cook, R; Couriel, D; Craddock, C; Damon, L; Deol, A; Desbrosses, Y; Devine, S; Di Grazia, C; Di Stasi, A; Dias, A; Dorritie, K; Essell, J; Eto, T; Farag, S; Forcade, E; Frankfurt, O; Fujiwara, S; Fukuda, T; Fukushima, K; Furst, S; Goto, T; Hall, A; Hatta, S; Hicheri, Y; Horwitz, M; Hou, H; How, J; Howard, D; Hsu, W; Huynh, A; Irvine, D; Ishikawa, T; Jamieson, K; Jedrzejczak, W; Jethava, Y; Jimenez, A; Jung, C; Kanda, J; Karakasis, D; Kato, J; Kekre, N; Khera, N; Kim, H; Klein, A; Kobbe, G; Kornblit, B; Kota, V; Lachance, S; Leber, B; Lee, C; Lee, J; Levis, M; Lin, T; Litzow, M; Liu, T; Martelli, M; Martinez, C; Matsuoka, K; Mccarty, J; Mendez, L; Michelis, F; Mikesch, J; Mineishi, S; Mishra, A; Mohty, M; Moors, I; Motyckova, G; Mueller, L; Muffly, L; Najima, Y; Nakamae, H; Nakano, N; Nathan, S; Nicholson, E; Norkin, M; Ogawa, Y; Olesen, G; Oluwole, O; Onozawa, M; Pantin, J; Papadopoulos, E; Paulson, K; Pemberton, L; Perera, T; Perl, A; Piatkowska-Jakubas, B; Poire, X; Protheroe, R; Rambaldi, A; Ritchie, D; Ross, K; Rubio, M; Santarone, S; Sanz Caballer, J; Sawa, M; Schaar, D; Scheid, C; Schriber, J; Seropian, S; Shah, N; Shah, N; Shore, T; Gil, J; Singh, A; Sobecks, R; Socie, G; Soiffer, R; Solh, M; Sprague, K; Spyridonidis, A; Stelljes, M; Stiff, P; Stuart, R; Tanaka, M; Tandra, A; Tholouli, E; Thomas, X; Thomson, K; Tiribelli, M; Tomlinson, B; Tsirigotis, P; Tzachanis, D; Uchida, N; Ueda, M; Ustun, C; Uy, G; Valcarcel Ferreiras, D; Vasu, S; Wagner, E; Waller, E; Watson, A; Weisdorf, D; Wingard, J; Wolschke, C; Wrobel, T; Yakoub-Agha, I; Yamauchi, T; Yared, J; Yeh, S; Yoon, S; Yoshihara, S; Null, N
Hypoplasia of the Spleen: Rare and Puzzling
2024 Cantoni, S; Pappalettera, L; Vanzulli, A; Cairoli, R
Impaired survival of patients with non donor-specific anti-HLA antibodies before HLA-mismatched allogeneic stem cell transplantation
2024 Milano, A; Lando, G; Di Maggio, G; Cornacchini, G; Grillo, G; Cairoli, R; Rossini, S; Crocchiolo, R
Long-term survival can be achieved in a significant fraction of older patients with core binding factor acute myeloid leukemia treated with intensive chemotherapy
2024 Mosna, F; Borlenghi, E; Litzow, M; Byrd, J; Papayannidis, C; Tecchio, C; Ferrara, F; Marcucci, G; Cairoli, R; Morgan, E; Gurrieri, C; Yeung, C; Deeg, H; Capelli, D; Candoni, A; Gotlib, J; Lunghi, M; Pullarkat, S; Lanza, F; Galimberti, S; Forghieri, F; Venditti, A; Festuccia, M; Audisio, E; Marvalle, D; Rigolin, G; Roti, G; Dibona, E; Visani, G; Albano, F; Eisfeld, A; Valent, P; Huls, G; Borthakur, G; Krampera, M; Martinelli, G; Kröger, N; Sperotto, A; Gottardi, M
Lymphoma’s last therapeutic option: Freeze it!
2024 Bassi, G; Ferrari, M; Vanzulli, A; Cantoni, S; Cairoli, R
Mutational Landscape of Bone Marrow CD19 and CD138 Cells in Waldenström Macroglobulinemia (WM) and IgM Monoclonal Gammopathy of Undetermined Significance (IgM MGUS)
2024 Trojani, A; Beghini, A; Bossi, L; Stefanucci, M; Palumbo, C; Greco, A; Frustaci, A; Di Camillo, B; Cairoli, R
Myeloma’s multiple morphologies
2024 Cantoni, S; Galitzia, A; Mancini, V; Cafro, A; Cairoli, R
Risk-adapted MRD-directed therapy for young adults with acute myeloid leukemia: 6-year update of the GIMEMA AML1310 trial
2024 Venditti, A; Piciocchi, A; Candoni, A; Arena, V; Palmieri, R; Fili, C; Carella, A; Calafiore, V; Cairoli, R; De Fabritiis, P; Storti, G; Salutari, P; Lanza, F; Martinelli, G; Curti, A; Luppi, M; Ingrosso, C; Martelli, M; Cuneo, A; Albano, F; Mule, A; Tafuri, A; Cudillo, L; Tieghi, A; Fracchiolla, N; Capelli, D; Trisolini, S; Alati, C; La Sala, E; Maurillo, L; Del Principe, M; Consalvo, M; Divona, M; Ottone, T; Cerretti, R; Sconocchia, G; Voso, M; Fazi, P; Vignetti, M; Buccisano, F
Sabatolimab plus hypomethylating agents in previously untreated patients with higher-risk myelodysplastic syndromes (STIMULUS-MDS1): a randomised, double-blind, placebo-controlled, phase 2 trial
2024 Zeidan, A; Ando, K; Rauzy, O; Turgut, M; Wang, M; Cairoli, R; Hou, H; Kwong, Y; Arnan, M; Meers, S; Pullarkat, V; Santini, V; Malek, K; Kiertsman, F; Niolat, J; Ramos, P; Menssen, H; Fenaux, P; Miyazaki, Y; Platzbecker, U
A Nine-Gene Expression Signature Distinguished a Patient with Chronic Lymphocytic Leukemia Who Underwent Prolonged Periodic Fasting
2023 Bossi, L; Palumbo, C; Trojani, A; Melluso, A; Di Camillo, B; Beghini, A; Sarnataro, L; Cairoli, R